Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I/II Study of Niraparib With Radiotherapy for Treatment of Metastatic Invasive Carcinoma of the Cervix

Trial Profile

Phase I/II Study of Niraparib With Radiotherapy for Treatment of Metastatic Invasive Carcinoma of the Cervix

Not yet recruiting
Phase of Trial: Phase I/II

Latest Information Update: 18 Jan 2019

At a glance

  • Drugs Niraparib (Primary) ; Carboplatin; Paclitaxel
  • Indications Adenocarcinoma; Cervical cancer; Squamous cell cancer
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms NIVIX
  • Most Recent Events

    • 10 Jan 2019 Planned initiation date changed from 17 Sep 2018 to 21 Apr 2019.
    • 29 Aug 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top